Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer
Clinical trial NCT00004925 · COMPLETED
Trial details
- NCT number
- NCT00004925
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-08-01
- Primary completion
- 2003-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.